An experimental study for methods, tests, subjective assessments used to check safety and effectiveness of Hair Care Range of Products.
- Registration Number
- CTRI/2023/02/050050
- Lead Sponsor
- ovoBliss Research Private Limited
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 40
1) Age: 18-75 years (both inclusive) at the time of consent.
2) Sex: Males and non-pregnant/non-lactating females (preferably equal number of males and females).
3) Females of childbearing potential must have a self-reported negative urine pregnancy.
4)Subject is in good general health as determined by the Investigator on the basis of medical history.
5) Subject is willing and able to follow and allow study staff to perform study test methods.
6) Subject is willing and able to follow the study directions, participate in the study, returning for all specified visits.
7) Subject must be able to understand and provide written informed consent to participate in the study.
1) Subject have history of allergy to any ink.
2) Subject have participated any clinical research study related to hair care products.
3) Subject having history of diabetes
4) Subject have history of mastectomy for cancer involving removal of lymph nodes within the past year, or treatment of any type of cancer within the last 6 months.
5) Subject having known history of any skin diseases including eczema, atopic dermatitis or active cancer.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The objective of this validation study is to evaluate the standardize the methods, procedural steps, validate the hair growth rate measurement, 60-s combing test, pull test, pluck test, subjective scoring of Hair quality appearance and scalp condition - evaluations techniques that are used during the conduct of clinical safety and efficacy studies for hair care product evaluation at/by NovoBliss Research on healthy adult human subjectsTimepoint: Day 01 and Day 04
- Secondary Outcome Measures
Name Time Method ot Applicable <br/ ><br>Timepoint: NONE